CD48: A co-stimulatory receptor of immunity

被引:61
作者
Elishmereni, Moran
Levi-Schaffer, Francesca [1 ,2 ]
机构
[1] Hebrew Univ Jerusalem, Sch Pharm, Fac Med, Dept Pharmacol & Expt Therapeut,Inst Drug Res, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Sch Pharm, Alex Grass & Brettler Ctr, IL-91120 Jerusalem, Israel
基金
以色列科学基金会;
关键词
CD48; Glycosyl-phosphatidyl-inositol (GPI); CD2; family; 2B4; T-CELL-ACTIVATION; ANCHORED PROTEINS; 2B4; CD244; NK CELLS; SIGNAL-TRANSDUCTION; GENETIC-LINKAGE; EXPRESSION; LEUKOCYTES; ANTIGEN; MOUSE;
D O I
10.1016/j.biocel.2010.09.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The CD48 molecule is a glycosyl-phosphatidyl-inositol (GPI)-anchored cell-surface protein of the CD2 family of molecules. Originally described on virally-induced B cells, CD48 has been found on various hematopoietic cells, and its expression is regulated by viral and bacterial products and immune-associated proteins. CD48 binds CD2 and other molecules, yet its high-affinity ligand in both mouse and human systems is 2B4. Despite its lack of an intracellular domain, stimulation of CD48 induces rearrangement of signaling factors in lipid rafts, Lck-kinase activity, and tyrosine phosphorylation. As an adhesion and co-stimulatory molecule, CD48 induces numerous effects in B and T lymphocytes, natural killer cells, mast cells, and eosinophils. Some of these depend upon cell-cell interactions via 284-CD48 binding. The structural and phenotypic characteristics of CD48, and its role in physiological and pathophysiological processes, are reviewed herein. Possible CD48-based applications for immune-impaired and inflammatory disorders are discussed as well. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 30 条
[1]   2B4 co-stimulation: NK cells and their control of adaptive immune responses [J].
Assarsson, E ;
Kambayashi, T ;
Persson, CM ;
Ljunggren, HG ;
Chambers, BJ .
MOLECULAR IMMUNOLOGY, 2005, 42 (04) :419-423
[2]   2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes [J].
Boles, KS ;
Stepp, SE ;
Bennett, M ;
Kumar, V ;
Mathew, PA .
IMMUNOLOGICAL REVIEWS, 2001, 181 :234-249
[3]   ANTI-CD48 (MURINE CD2 LIGAND) MABS SUPPRESS CELL-MEDIATED-IMMUNITY IN-VIVO [J].
CHAVIN, KD ;
QIN, LH ;
LIN, JX ;
WOODWARD, J ;
BALIGA, P ;
KATO, K ;
YAGITA, H ;
BROMBERG, JS .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (05) :701-709
[4]   Molecular basis of the dual functions of 2B4 (CD244) [J].
Chlewicki, Lukasz K. ;
Velikovsky, C. Alejandro ;
Balakrishnan, Vamsi ;
Mariuzza, Roy A. ;
Kumar, Vinay .
JOURNAL OF IMMUNOLOGY, 2008, 180 (12) :8159-8167
[5]   CD48-deficient mice have a pronounced defect in CD4+ T cell activation [J].
González-Cabrero, J ;
Wise, CJ ;
Latchman, Y ;
Freeman, GJ ;
Sharpe, AH ;
Reiser, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1019-1023
[6]   Signal transduction in leucocytes via GPI-anchored proteins:: an experimental artefact or an aspect of immunoreceptor function? [J].
Horejsí, V ;
Cebecauer, M ;
Cerny, J ;
Brdicka, T ;
Angelisová, P ;
Drbal, K .
IMMUNOLOGY LETTERS, 1998, 63 (02) :63-73
[7]   CD48 IS A COUNTER-RECEPTOR FOR MOUSE CD2 AND IS INVOLVED IN T-CELL ACTIVATION [J].
KATO, K ;
KOYANAGI, M ;
OKADA, H ;
TAKANASHI, T ;
WONG, YW ;
WILLIAMS, AF ;
OKUMURA, K ;
YAGITA, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1241-1249
[8]  
Katsuura M, 1998, ACTA PAEDIATR JAPON, V40, P580
[9]   FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells [J].
Khan, Naveed Ahmed ;
Kim, Yuri ;
Shin, Sooan ;
Kim, Kwang Sik .
CELLULAR MICROBIOLOGY, 2007, 9 (01) :169-178
[10]   PHYSICAL AND GENETIC-LINKAGE OF THE GENES ENCODING LY-9 AND CD48 ON MOUSE AND HUMAN-CHROMOSOMES-1 [J].
KINGSMORE, SF ;
SOURYAL, CA ;
WATSON, ML ;
PATEL, DD ;
SELDIN, MF .
IMMUNOGENETICS, 1995, 42 (01) :59-62